JNJJohnson & Johnson
271.49USD-0.70%Mkt Cap: 658.89B $P/E: 31.72

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine…

Key Statistics

Company
Market Cap658.89B $
Enterprise Value672.61B $
Revenue (TTM)97.93B $
Gross Profit63.94B $
Net Income (TTM)26.80B $
Revenue/Share40.67 USD
Last Price271.49 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees138.2K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS4781601046
Valuation
P/E (Trailing)31.72
P/E (Forward)21.72
PEG4.79
EV/EBITDA19.29
EV/Revenue6.87
P/S6.58
P/B7.58
EPS (TTM)8.42
EPS (Forward)12.31
52W Range
173.3395% of range276.47
52W High276.47 USD
52W Low173.33 USD
Profitability
Gross Margin67.88%
Oper. Margin29.19%
EBITDA Margin35.61%
Profit Margin28.46%
ROE32.87%
ROA13.46%
Growth
Revenue Growth6.60%
Earnings Growth-0.90%
Cash Flow & Leverage
Operating CF24.53B $
CapEx (TTM)5.22B $
FCF Margin17.24%
FCF Yield2.56%
Net Debt28.28B $
Net Debt/EBITDA0.81
Balance Sheet
Debt/Equity0.59
Current Ratio1.09
Quick Ratio0.72
Book Value/Sh35.28 USD
Cash/Share8.614 USD
Dividends
Fwd Div Rate5.360 USD
Trail. Div Rate5.240 USD
Div. Yield1.96%
5Y Avg Yield2.77%
Payout Ratio60.79%
Ex-Div DateAug 25, 2026
Pay DateSep 8, 2026
Splits
Last Split2:1
Split DateJun 13, 2001
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)272.50 USD
Upside (mean)+0.4%
Target Range190.00 USD305.00 USD
$190.00+0.4% to mean$305.00
# Analysts22
Ownership
Shares Out.2.41B
Float2.41B
Insiders0.05%
Institutions76.91%
Short Interest
Short Ratio3.2d
Short % Float1.17%
Short % Out.1.05%
Shares Short25.41M
Short (prev mo.)26.58M
Technical
SMA 50254.19 (+6.8%)
SMA 200231.39 (+17.3%)
Beta0.23
S&P 52W Chg18.16%
Avg Vol (30d)5.39M
Avg Vol (10d)6.35M
Technical Indicators
RSI (14)68.4
MACD3.3610
MACD Signal2.8158
MACD Hist.+0.5453
BB Upper270.16 USD
BB Middle260.63 USD
BB Lower251.09 USD
BB Width7.32%
ATR (14)6.172 USD
Vol Ratio (20d)1.27x